Related Experiment Videos
Antibiotics for inflammatory bowel disease: do they work?
1Gastroenterology Unit, S. Raffaele University Hospital, Milan, Italy. guslandi.mario@hsr.it
European Journal of Gastroenterology & Hepatology
|January 28, 2005
Summary
Antibiotics like metronidazole and ciprofloxacin may help inflammatory bowel disease (IBD) patients, but more research is needed. Long-term use shows benefits for Crohn's disease, though side effects are a concern.
Area of Science:
- Gastroenterology
- Microbiology
Background:
- Intestinal flora is increasingly implicated in the pathogenesis of inflammatory bowel disease (IBD).
- Antibacterial agents are used as adjunctive therapy for ulcerative colitis and Crohn's disease.
Purpose of the Study:
- To review the current evidence on antibiotic use in IBD.
- To assess the efficacy and limitations of commonly used antibiotics in IBD management.
Main Methods:
- Review of controlled trials and clinical data on antibiotic treatment in IBD.
- Analysis of antibiotic efficacy in specific IBD subtypes and conditions.
Main Results:
- Metronidazole and ciprofloxacin are frequently used, with some evidence of clinical benefit.
- Controlled trials are limited, hindering definitive conclusions and treatment guidelines.
- Long-term antibiotic therapy shows promise for Crohn's disease, pouchitis, and perianal Crohn's disease.
- Systemic side effects can impact long-term tolerability.
Conclusions:
- Antibiotic therapy offers potential benefits in specific IBD contexts, particularly long-term Crohn's disease management.
- Further investigation into non-absorbable agents like rifaximin is warranted.
- Clear therapeutic guidelines for antibiotic use in IBD are currently lacking.